Alnylam Ready To Expand TTR Franchise With Positive Cardiomyopathy Results

Supplemental Onpattro US Filing Planned For Late 2022

 
• By Mandy Jackson
  
RNA, Epigenetics concept, 3d illustration
Onpattro silences the RNA that makes the TTR protein • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D